Results 101 to 110 of about 179,953 (145)

Improvement of magnetic resonance imaging diffusion metric 'slow diffusion coefficient (SDC)' over apparent diffusion coefficient (ADC) for isocitrate dehydrogenase (IDH) genotyping in diffuse gliomas. [PDF]

Quant Imaging Med Surg
Zheng WY, Shi YT, He YY, Lin RL, Xiao BH, Jiang RF, Wáng YXJ.   +6 more
europepmc   +1 more source

Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning. [PDF]

Sci Rep, 2020
Liu S, Shah Z, Sav A, Russo C, Berkovsky S, Qian Y, Coiera E, Di Ieva A.   +7 more
europepmc   +1 more source

Survival Impact of Isocitrate Dehydrogenase (IDH)-Wildtype Histological Versus Molecular Glioblastoma: A Propensity Score-Matched Analysis. [PDF]

Cureus
Patil N, Dube S, Mutua F, Kakumanu S, Shankar JJ, Sinha N, Pareek V.   +6 more
europepmc   +1 more source

The value of multi-parametric magnetic resonance imaging (MRI) radiomics in predicting isocitrate dehydrogenase (IDH) wildtype with telomerase reverse tranase (TERT) promoter mutation in glioma. [PDF]

Quant Imaging Med Surg
Wang J, Qu D, Zhang H, Zhang H.
europepmc   +1 more source

Isocitrate Dehydrogenase (IDH)-Mutant High-Grade Glioma in the Cerebellum: A Case Report. [PDF]

Cureus
Dinesh D, Johnson T, P K D, Rengarajan S, Indiran V.   +4 more
europepmc   +1 more source

The long non-coding RNA Cancer Susceptibility 15 (CASC15) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia. [PDF]

Haematologica, 2020
Grasedieck S, Ruess C, Krowiorz K, Lux S, Pochert N, Schwarzer A, Klusmann JH, Jongen-Lavrencic M, Herold T, Bullinger L, Pollack JR, Rouhi A, Kuchenbauer F.   +12 more
europepmc   +1 more source

The Correlation Patterns of miRNA Expression with Targeted mRNA Transcripts in Glioma Patients with Wild-Type and Mutated Isocitrate Dehydrogenase (IDH) Genotypes. [PDF]

Acta Naturae
Bondarev AA, Evpak AS, Novoselov AL, Kudriaeva AA, Jr Belogurov AA.   +4 more
europepmc   +1 more source

The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs). [PDF]

Cancers (Basel)
Pierangeli S, Donnini S, Ciaurro V, Milano F, Cardinali V, Sciabolacci S, Cimino G, Gionfriddo I, Ranieri R, Cipriani S, Padiglioni E, Iacucci Ostini R, Zei T, Pierini A, Martelli MP.   +14 more
europepmc   +1 more source

Leptomeningeal Dissemination Complicated With Acute Tetraplegia From a Supratentorial Multicentric Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastoma: A Case Report. [PDF]

Cureus
Visarion DM, Cale I, Miron I, David BI, Petrescu GE, Pruna VM.   +5 more
europepmc   +1 more source